期刊
MOLECULAR THERAPY-ONCOLYTICS
卷 23, 期 -, 页码 458-476出版社
CELL PRESS
DOI: 10.1016/j.omto.2021.11.005
关键词
-
资金
- National Natural Science Foundation of China [81802822]
- Natural Science Foundation of Shandong Province [ZR2018BH017, ZR202102220061]
- China Postdoctoral Science Foundation [2018M642607]
- Qingdao Applied Basic Research Project [19-6-2-50-cg]
Gastric cancer is a prevalent malignant tumor with high morbidity and mortality due to a lack of novel therapeutic strategies. Long non-coding RNAs play crucial roles in various aspects of gastric cancer pathogenesis and may serve as potential biomarkers for diagnosis, prognosis, and therapeutic targets.
Gastric cancer (GC) is one of the most prevalent malignant tumor types and the third leading cause of cancer-related death worldwide. Its morbidity and mortality are very high due to a lack of understanding about its pathogenesis and the slow development of novel therapeutic strategies. Long non-coding RNAs (lncRNAs) are a class of non-coding RNAs with a length of more than 200 nt. They play crucial roles in a wide spectrum of physiological and pathological processes by regulating the expression of genes involved in proliferation, differentiation, apoptosis, cell cycle, invasion, metastasis, DNA damage, and carcinogenesis. The aberrant expression of lncRNAs has been found in various cancer types. A growing amount of evidence demonstrates that lncRNAs are involved in many aspects of GC pathogenesis, including its occurrence, metastasis, and recurrence, indicating their potential role as novel biomarkers in the diagnosis, prognosis, and therapeutic targets of GC. This review systematically summarizes the biogenesis, biological properties, and functions of lncRNAs and highlights their critical role and clinical significance in GC. This information may contribute to the development of better diagnostics and treatments for GC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据